Sat. Dec 2nd, 2023
A hypercompact Cas protein similar to CRISPR-Cas9, the revolutionary gene-editing tool, should allow easier viral delivery for gene therapy in humans and crops


By Richard Moran

Richard Moran loves to write about sports with the Golden State Online. Before that, he worked as a senior writer at ESPN. Richard grew up in San Diego and graduated from the University of San Diego in 2004, after which he worked as an editor for five years.

Leave a Reply